Keyphrases
Primary Debulking Surgery
61%
Ovarian Cancer
56%
Ovarian Cancer Patients
44%
Neoadjuvant Chemotherapy
41%
Stage IIIC
35%
Endometrial Cancer
31%
Denmark
27%
Advanced Ovarian Cancer
25%
Cancer Patients
25%
Human Epididymis Protein 4
20%
Preoperative Evaluation
18%
Epithelial Ovarian Cancer
17%
Tumor Removal
15%
Cancer-specific Survival
15%
Interval Debulking Surgery
14%
Multicenter Cohort Study
14%
Residual Disease
12%
CA-125 Levels
12%
Debulking
12%
Incidence Trends
12%
Young Women
12%
Long-term Survival
12%
Centralized Treatment
12%
Four-level
12%
High-risk Endometrial Cancer
12%
Young Patients
12%
Ovarian Cancer Screening
12%
Treatment Trends
12%
Survival Trends
12%
Access to Treatment
12%
Prospective Comparative Study
12%
Ultrasound
12%
Treatment Strategy
12%
Non-invasive Prediction
12%
Diagnostic Strategy
12%
Diagnostic Accuracy
12%
Disease Stage
12%
18F-FDG PET-CT
12%
Preoperative Staging
12%
SUVmax
12%
Novel Index
12%
Risk of Malignancy Index
12%
Disease Comorbidity
12%
Primary Surgery
12%
Positron Emission Tomography-computed Tomography (PET-CT)
12%
Pelvic Mass
12%
PET-MRI
12%
Socioeconomic Differences
12%
Advanced Stage
12%
Non-invasive Assessment
12%
Medicine and Dentistry
Ovarian Cancer
100%
Cytoreductive Surgery
70%
Debulking Surgery
62%
Neoadjuvant Chemotherapy
39%
Endometrial Cancer
37%
Positron Emission Tomography-Computed Tomography
25%
Krukenberg Tumor
23%
Human Epididymis Protein 4
21%
Disease
19%
Preoperative Evaluation
18%
Neoplasm
17%
Malignant Neoplasm
16%
Cancer Therapy
14%
Overall Survival
14%
Prognostic Factor
12%
CA-125
12%
Cohort Analysis
12%
Debulking
12%
Magnetic Resonance Imaging
12%
Biological Marker
12%
Long Term Survival
12%
Pelvis
12%
Patient Referral
12%
Diagnostic Accuracy
12%
Cancer
12%
Diagnosis
12%
Female Genital Tract Cancer
9%
Lymph Node Metastasis
9%
Cancer Staging
8%
Triage
8%
Minimal Residual Disease
6%
Risk Stratification
6%
Tumor Antigen
6%
Cancer Specific Survival
6%